Dishman Pharmaceuticals plans to raise Rs750mn by next month via non-convertible bonds, the MD, J.R. Vyas was quoted as saying. The company plans to use the funds to finance Rs1bn investment in four new drug-making plants, he added.The stock erased early gains and ended lower by 0.6% at Rs219. It opened at Rs221 it touched an intra-day high of Rs223 and a low of Rs217 and recorded volumes of over 91,000 shares on BSE.
